Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.54 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.47 |
| ▸ | PELP1 | Q8IZL8 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ESRRA | P11474 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28317018 | 0.88 | PDK1 (0.69) | ALDH1A1HPGDNPSR1PDK1VCAM1 | |
| SCHEMBL17055961 | 0.84 | ALDH1A1 (0.55) | ALDH1A1HPGDNPSR1PDK1VCAM1 | |
| SCHEMBL12352847 | 0.84 | ALDH1A1 (0.55) | ALDH1A1HPGDNPSR1PDK1VCAM1 | |
| SCHEMBL31750708 | 0.84 | ALDH1A1 (0.55) | ALDH1A1HPGDNPSR1PDK1VCAM1 | |
| SCHEMBL12352878 | 0.84 | ALDH1A1 (0.55) | ALDH1A1HPGDNPSR1PDK1VCAM1 | |
| SCHEMBL27172514 | 0.84 | ALDH1A1 (0.57) | ALDH1A1HPGDNPSR1PDK1VCAM1 | |
| SCHEMBL12352850 | 0.83 | KMT2A (0.57) | ALDH1A1HPGDNPSR1PDK1VCAM1 | |
| SCHEMBL30445111 | 0.82 | ALDH1A1 (0.65) | ALDH1A1HPGDNPSR1VCAM1KMT2A | |
| SCHEMBL7566531 | 0.82 | ALDH1A1 (0.65) | ALDH1A1HPGDNPSR1VCAM1KMT2A | |
| SCHEMBL2244840 | 0.81 | KMT2A (0.57) | ALDH1A1HPGDNPSR1PDK1VCAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030078249-A1 | VLA-4 inhibitor compounds | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2003-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030078249-A1 | VLA-4 inhibitor compounds | VCAM1, ICAM1, ITGA4 | ALDH1A1 146/4885HPGD 4160/4885NPSR1 2506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.